Robert M. Gumtow Scholarship Fund

Robert M. Gumtow outside of his office at the University at Buffalo.

Pharmacy students in the professional practice program receive scholarships through this fund, named for a former professor.

Robert H. Gumtow was a beloved colleague and faculty member who taught in the UB School of Pharmacy and Pharmaceutical Sciences for more than thirty years.

This fund, established in 1995 by friends of the School of Pharmacy and Pharmaceutical Sciences, provides an annual scholarship to a student in the professional practice program.

Gumtow served in an army during the Korean War, during which he was left partially paralyzed and an amnesiac. He recovered, and these dramatic personal experiences were instrumental in teaching him to persevere through any obstacle. He served as a model and inspiration for the many students he counseled through pharmacy-student affairs, advisor to the pharmacy academic honor society, Rho Chi, and those for whom he taught pharmacy education.

Author and co-author of numerous papers, he was a member of the American Pharmaceutical Association, the American Association for the Advancement of Science, the American Association of Colleges of Pharmacy, and the Pharmaceutical Society of Japan, and also received the Chancellor’s Award for Excellence in Teaching.

Professor Gumtow passed away in 1994 at the age of 64 immediately after retiring from the School.

Other Pharmacy and Pharmaceutical Sciences Funds

News from School of Pharmacy and Pharmaceutical Sciences

  • UB CIGBS Announces Stop Diabetes Progression, a New Global Community Health Site Initiative
    10/18/23
    The University at Buffalo (UB) Center for Integrated Global Biomedical Sciences (CIGBS) has announced plans to launch, Stop Diabetes Progression, a new health initiative, focusing on the creation of community-based education networks in Western New York, Jamaica and Zimbabwe to engage individuals with pre-diabetes and those with an established diagnosis of diabetes mellitus. The goal of this new initiative is to stop the progression of the disease for both groups.
  • Fond Memories of UB
    5/10/20
    Linda Edelman, BS ’66, PharmD, leaves a generous bequest.
  • UB Pharmacy Announces 2023 Alumni Award Winners
    7/14/23
    BUFFALO, N.Y. — The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is proud to announce the recipients of its 2023 alumni awards. Awardees will be honored at a ceremony on October 13, 2023, at the Pharmacy Building on UB’s South Campus.
  • Pattin appointed clinical associate professor in the Division of Outcomes and Practice Advancement
    5/19/23
    In July, Anthony Pattin, PharmD, will join University at Buffalo School of Pharmacy and Pharmaceutical Sciences (SPPS) faculty as a clinical associate professor in the Division of Outcomes and Practice Advancement (OPA), Department of Pharmacy Practice. In this post, Pattin will coordinate and teach pharmacy law and maintain an experiential training site and research program in community pharmacy practice.
  • UB Center for Integrated Global Biomedical Sciences receives NIH funding for Cloud-based Viral Surveillance Research Training Program in Jamaica
    8/9/23
    The Center for Integrated Global Biomedical Sciences at the University at Buffalo (UB), State University of New York (SUNY) has received funding to expand its Global Infectious Diseases (GID) Research Training Program. The GID is supported by the Fogarty International Center at the National Institutes of Health (NIH) for pre-doctoral and post-doctoral training that will lead to capacity building in Jamaica through UB/SUNY and the University of the West Indies (UWI) collaboration. Importantly, this new funding includes CTIS, a key cloud project implementation partner, and a women-owned small business with expertise in providing informatics solutions for clinical trials and research for over 30 years.
  • Qu receives NIH grant to develop targeted mass spectrometry assays as markers in monitoring Type 1 diabetes
    9/5/23
    Jun Qu, PhD, professor, Department of Pharmaceutical Sciences, has been awarded a four-year $982,617 U01 grant from the National Institutes of Health (NIH). The study, called “Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications,” will develop novel, highly sensitive assays that quantify proteins or peptide hormones to effectively monitor the progression or efficacy of new clinical interventions prior to or following the onset of Type 1 diabetes.
  • Meaney named ACCP Fellow
    8/14/23
    Calvin Meaney, PharmD, clinical associate professor and interim division head, Division of Outcomes and Practice Advancement, Department of Pharmacy Practice, has been named a Fellow of the American College of Clinical Pharmacy (ACCP).